Henstedt-Ulzburg, Germany

David Gene Barrett



Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Henstedt-Ulzburg, DE (2008 - 2009)
  • Zionsville, IN (US) (2012)

Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: David Gene Barrett: Innovator in Pharmaceutical Compounds

Introduction

David Gene Barrett is a notable inventor based in Henstedt-Ulzburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating diabetes and obesity. With a total of 3 patents to his name, Barrett's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents, Barrett has developed GPR119 agonists, which include compounds designed for the treatment of diabetes and obesity. These compounds are formulated to enhance the activity of the GPR119 receptor, which plays a crucial role in glucose metabolism. Another significant patent involves substituted arylcyclopropylacetamides as glucokinase activators. This invention provides compounds that can activate glucokinase, an important enzyme in glucose regulation, along with their pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Barrett has worked with prominent companies in the pharmaceutical industry. He has been associated with Eli Lilly and Company, where he contributed to various innovative projects. Additionally, he has worked with SmithKline Beecham Corporation, further enhancing his expertise in drug development and research.

Collaborations

Barrett has collaborated with several professionals in his field, including Andreas Gerhard Weichert and Stefan Heuser. These collaborations have likely enriched his research and contributed to the success of his inventions.

Conclusion

David Gene Barrett is a distinguished inventor whose work in pharmaceutical compounds has advanced the treatment options for diabetes and obesity. His patents reflect a commitment to innovation and improvement in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…